Collection-image

TOPICAL COLLECTIONS

Analysis And Imaging Of Osteocytes

Submit Abstract

Guest Editor

Eva S. Liu

Eva S. Liu

Harvard Medical School, Brigham and Women’s Hospital, Division of Endocrinology

Dr. Eva S. Liu received her BA in Biochemistry and Molecular Biology from Dartmouth College and her MD from New York University School of Medicine. She completed her internal medicine residency at Yale University School of Medicine and endocrinology fellowship at Brigham and Women’s Hospital. She carried out post-doctoral research in the Endocrine Unit at Massachusetts General Hospital on the molecular and hormonal regulation of complications of the rare skeletal disorder X-linked hypophosphatemia (XLH).  Dr. Liu is currently an Assistant Professor of Medicine in the Endocrine Division at Brigham and Women’s Hospital/Harvard Medical School. Her laboratory is focused on dissecting the pathophysiology of hypophosphatemic rickets and investigating the molecular and endocrine regulation of the maturation and pathologic mineralization of the bone-tendon attachment site (enthesis) as well as the molecular and hormonal regulation of osteocyte lacuno-canalicular (LCN) remodeling.  Specifically, Dr. Liu uses molecular/cellular, histological, and advanced imaging techniques to investigate in how mineral ions and hormones modulate osteocyte LCN remodeling.

Collection Overview

Osteocytes are highly specialized bone cells with diverse functions, including mechanosensation, regulation of bone resorption, and modulation of mineral metabolism through hormone secretion and signaling. These cells reside within lacunae embedded in a mineralized matrix, with an extensive network of dendritic processes housed in canaliculi that facilitate cell-cell communication and the transport of nutrients and small molecules.

Research suggests that osteocytes actively resorb the surrounding matrix to maintain skeletal integrity and mineral ion homeostasis. Additionally, osteocytes synthesize and secrete key regulatory hormones, such as fibroblast growth factor 23 (FGF23), which controls phosphate homeostasis, and sclerostin, which modulates bone formation. Their role in skeletal diseases is well established, as anti-sclerostin antibodies are used to treat low bone mass disorders, and mutations affecting FGF23 regulation contribute to conditions such as hypophosphatemic rickets.

This collection aims to consolidate a comprehensive set of methods and protocols for the study of osteocyte biology. It will encompass a range of established and emerging techniques, including in vitro osteocyte cell lines, mouse models, and advanced methods for visualizing osteocytes and their lacuno-canalicular network. By bringing together these diverse methodologies, this collection will serve as a valuable resource for researchers investigating osteocyte function and its implications in skeletal health and disease.

Articles

IDG-SW3 Cell Culture in a Three-Dimensional Extracellular Matrix
10:48

IDG-SW3 Cell Culture in a Three-Dimensional Extracellular Matrix

0 Views

•

Cited by 1

•

2023

•